ExQor Technologies
ExQor Technologies is pioneering biologic treatments aimed at restoring cognitive functions by regenerating neurons damaged by various diseases. Their innovative biologic is designed to address learning and memory issues more effectively and with fewer side effects than current treatments. The company has demonstrated preclinical success in treating cognitive impairments associated with Alzheimer's, HIV-related dementias, and substance addiction. ExQor is preparing its first IND application to the FDA for Alzheimer's treatment and plans to pursue additional applications for other neurodegenerative disorders. Additionally, ExQor is developing advanced MRI diagnostic agents to detect early-stage Alzheimer's, enhancing conventional MRI capabilities. With a strong AI background, ExQor aims to improve treatment precision and patient compliance through personalized approaches, supported by multiple patents and ongoing research.
ExQor Technologies
ExQor Technologies is pioneering biologic treatments aimed at restoring cognitive functions by regenerating neurons damaged by various diseases. Their innovative biologic is designed to address learning and memory issues more effectively and with fewer side effects than current treatments. The company has demonstrated preclinical success in treating cognitive impairments associated with Alzheimer's, HIV-related dementias, and substance addiction. ExQor is preparing its first IND application to the FDA for Alzheimer's treatment and plans to pursue additional applications for other neurodegenerative disorders. Additionally, ExQor is developing advanced MRI diagnostic agents to detect early-stage Alzheimer's, enhancing conventional MRI capabilities. With a strong AI background, ExQor aims to improve treatment precision and patient compliance through personalized approaches, supported by multiple patents and ongoing research.